AR002283A1 - Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas. - Google Patents

Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.

Info

Publication number
AR002283A1
AR002283A1 ARP960101766A AR10176696A AR002283A1 AR 002283 A1 AR002283 A1 AR 002283A1 AR P960101766 A ARP960101766 A AR P960101766A AR 10176696 A AR10176696 A AR 10176696A AR 002283 A1 AR002283 A1 AR 002283A1
Authority
AR
Argentina
Prior art keywords
therapy
women
premonopausic
perimenopausic
hormones
Prior art date
Application number
ARP960101766A
Other languages
English (en)
Inventor
Ursula Dr Lachnit-Fixon
Simiramis Dr Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR002283A1 publication Critical patent/AR002283A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Abstract

Se propone un preparado hormonal de acción anticonceptiva que a la vez sirve para la terapia de reemplazo de hormonas en mujeres perimenopáusicas ypremenopáusicas. Los medicamentos conocidos para este último fin no son eficaces como anticonceptivos. Para resolver este problema, el preparado delinvento contiene en calidad de sustancias activas un componente estrógeno natural (sin etinilestradiol) y un componente gestágeno. Con estemedicamento se logra una acción anticonceptivasegura junto con una terapia eficaz de las primeras manifestaciones de falta de estrógenos y la prevenciónde la osteoporosis.
ARP960101766A 1995-03-16 1996-03-15 Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas. AR002283A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen

Publications (1)

Publication Number Publication Date
AR002283A1 true AR002283A1 (es) 1998-03-11

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101766A AR002283A1 (es) 1995-03-16 1996-03-15 Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.

Country Status (17)

Country Link
EP (1) EP0814811A1 (es)
JP (1) JPH11501649A (es)
KR (1) KR19980703058A (es)
AR (1) AR002283A1 (es)
AU (1) AU713258B2 (es)
CA (1) CA2215382A1 (es)
CZ (1) CZ289697A3 (es)
DE (1) DE19510861A1 (es)
HU (1) HUP9801691A3 (es)
IL (1) IL117516A (es)
MX (1) MX9707009A (es)
NO (1) NO974255L (es)
NZ (1) NZ304027A (es)
PL (1) PL322202A1 (es)
SK (1) SK123997A3 (es)
WO (1) WO1996028165A1 (es)
ZA (1) ZA962177B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
IL117516A (en) 2000-07-26
NZ304027A (en) 2000-05-26
MX9707009A (es) 1997-11-29
NO974255L (no) 1997-11-14
AU5110896A (en) 1996-10-02
AU713258B2 (en) 1999-11-25
HUP9801691A2 (hu) 1998-11-30
EP0814811A1 (de) 1998-01-07
WO1996028165A1 (de) 1996-09-19
CZ289697A3 (en) 1997-12-17
CA2215382A1 (en) 1996-09-19
DE19510861A1 (de) 1996-09-19
JPH11501649A (ja) 1999-02-09
SK123997A3 (en) 1998-02-04
ZA962177B (en) 1996-07-29
IL117516A0 (en) 1996-07-23
NO974255D0 (no) 1997-09-15
PL322202A1 (en) 1998-01-19
KR19980703058A (ko) 1998-09-05
HUP9801691A3 (en) 1999-03-01

Similar Documents

Publication Publication Date Title
KR960700727A (ko) 호르몬 대체 치료(hormone replacement therapy)
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
DK0836506T4 (da) Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
YU54602A (sh) Drospirenon za terapiju zamene hormona
RU95118436A (ru) Гормональная заместительная терапия
PT835114E (pt) Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal
KR920011514A (ko) 프로게스토겐만을 함유하는 피임제
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
HUP9904344A2 (hu) Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
AR002283A1 (es) Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.
BR9708162A (pt) Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal
AR025443A1 (es) Una composicion farmaceutica para ser usada como anticonceptivo.
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
BR0309621A (pt) Uso de estrógenos conjugados em combinação com trimegestona na terapia de substituição de hormÈnios
HRP20020666B1 (en) Drospirenone for hormone replacement therapy
AR035633A1 (es) Drospirenona para terapia de reemplazo de hormonas
TH39540A (th) สารผสมที่ฉีดได้เดือนละครั้ง ซึ่งเป็นยาคุมกำเนิดดีพอท และสำหรับรักษาโรคโดยการแทนชอร์โมนสำหรับผู้หญิงวัยใกล้หมดประจำเดือนและวัยก่อนหมดประจำเดือน
Huffman Oral Contraceptives vs. a weekly contraceptive patch
TH27339A (th) ฮอร์โมนตัวใหม่ที่ใช้เป็นยาและประโยชน์ของมันในการรักษาภาวะขาดเอสโตเจน
UY26539A1 (es) Drospirenona para terapia de reemplazo de hormonas.
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method